share_log

Select Medical Hldgs Analyst Ratings

Benzinga ·  Aug 7, 2023 08:02
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/07/2023 6.84% Credit Suisse $29 → $32 Maintains Neutral
07/20/2023 26.88% RBC Capital → $38 Reiterates Outperform → Outperform
05/08/2023 26.88% RBC Capital $32 → $38 Maintains Outperform
05/08/2023 -3.17% Credit Suisse → $29 Reiterates → Neutral
02/27/2023 30.22% Benchmark → $39 Reiterates → Buy
02/27/2023 -3.17% Credit Suisse $24 → $29 Maintains Neutral
11/07/2022 6.84% RBC Capital $36 → $32 Maintains Outperform
05/17/2022 -9.85% Credit Suisse $28 → $27 Maintains Neutral
05/10/2022 20.2% RBC Capital $42 → $36 Maintains Outperform
03/16/2022 -6.51% Credit Suisse $37 → $28 Maintains Neutral
03/07/2022 40.23% RBC Capital $47 → $42 Maintains Outperform
01/18/2022 16.86% B of A Securities $40 → $35 Maintains Buy
01/18/2022 56.93% RBC Capital $50 → $47 Maintains Outperform
08/10/2021 30.22% Credit Suisse $37 → $39 Maintains Neutral
05/10/2021 53.59% Deutsche Bank $42 → $46 Maintains Buy
03/01/2021 13.52% Credit Suisse $32 → $34 Maintains Neutral
01/05/2021 -9.85% Credit Suisse $22 → $27 Maintains Neutral
11/02/2020 -26.54% Credit Suisse $19 → $22 Maintains Neutral
08/04/2020 -13.19% Deutsche Bank $24 → $26 Maintains Buy
08/03/2020 -36.56% Credit Suisse $18 → $19 Maintains Neutral
06/16/2020 -49.92% B of A Securities $18 → $15 Downgrades Neutral → Underperform
05/04/2020 -39.9% Credit Suisse $23 → $18 Maintains Neutral
04/24/2020 -19.87% Deutsche Bank $33 → $24 Maintains Buy
04/03/2020 -23.21% Credit Suisse $29 → $23 Maintains Neutral
03/24/2020 -16.53% Benchmark $33 → $25 Reiterates → Buy
02/24/2020 10.18% Deutsche Bank $22 → $33 Maintains Buy
11/04/2019 -23.21% Benchmark $21 → $23 Maintains Buy
09/17/2019 -26.54% Deutsche Bank → $22 Initiates Coverage On → Buy
05/17/2019 -39.9% JMP Securities → $18 Upgrades Market Perform → Market Outperform
01/07/2019 -46.58% Credit Suisse $21 → $16 Maintains Neutral
12/14/2018 -33.22% Barclays → $20 Initiates Coverage On → Equal-Weight
11/05/2018 -29.88% Credit Suisse $18 → $21 Maintains Neutral
10/16/2018 -39.9% Credit Suisse → $18 Initiates Coverage On → Neutral

What is the target price for Select Medical Hldgs (SEM)?

The latest price target for Select Medical Hldgs (NYSE: SEM) was reported by Credit Suisse on August 7, 2023. The analyst firm set a price target for $32.00 expecting SEM to rise to within 12 months (a possible 6.84% upside). 7 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Select Medical Hldgs (SEM)?

The latest analyst rating for Select Medical Hldgs (NYSE: SEM) was provided by Credit Suisse, and Select Medical Hldgs maintained their neutral rating.

When is the next analyst rating going to be posted or updated for Select Medical Hldgs (SEM)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Select Medical Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Select Medical Hldgs was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.

Is the Analyst Rating Select Medical Hldgs (SEM) correct?

While ratings are subjective and will change, the latest Select Medical Hldgs (SEM) rating was a maintained with a price target of $29.00 to $32.00. The current price Select Medical Hldgs (SEM) is trading at is $29.95, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment